Thus, based on the WHO CNS5 grading criteria, all tumours presented with histological criteria warranting an IDH-mutant astrocytoma CNS WHO grade 4 designation due to either presence of necrosis or vascular proliferation (Online Resource in supplementary Table 1). The gene discussed is IDH2; the disease is neoplasm.